Industry-Expert Theater

Identifying and Treating Patients With Non-Metastatic Castration Resistant Prostate Cancer

Tuesday, September 17
10:15 AM - 11:15 AM
Location: Theater 1, Innovation Hub

At Janssen Biotech, Inc. we have an urgent commitment to make a difference for cancer patients and those living with autoimmune diseases. Comprised of Janssen Oncology and Janssen Immunology, we deliver transformational biologic medicines to market, and have built a rich legacy of innovative firsts. For more information, visit www.janssen.com.

Company: Janssen Biotech
Contact: Matt Haemmerle
Phone: 850-543-3374
Email: mhaemmer@its.jnj.com


Assets

Identifying and Treating Patients With Non-Metastatic Castration Resistant Prostate Cancer



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Identifying and Treating Patients With Non-Metastatic Castration Resistant Prostate Cancer